These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37482041)

  • 1. Crosstalk between oxidative stress and epigenetic marks: New roles and therapeutic implications in cardiac fibrosis.
    Liu ZY; Song K; Tu B; Lin LC; Sun H; Zhou Y; Li R; Shi Y; Yang JJ; Zhang Y; Zhao JY; Tao H
    Redox Biol; 2023 Sep; 65():102820. PubMed ID: 37482041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial quality control in cardiac fibrosis: Epigenetic mechanisms and therapeutic strategies.
    Lin LC; Tu B; Song K; Liu ZY; Sun H; Zhou Y; Sha JM; Yang JJ; Zhang Y; Zhao JY; Tao H
    Metabolism; 2023 Aug; 145():155626. PubMed ID: 37302693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.
    Peng ML; Fu Y; Wu CW; Zhang Y; Ren H; Zhou SS
    Front Endocrinol (Lausanne); 2022; 13():907757. PubMed ID: 35784531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Regulation of Fibroblasts and Crosstalk between Cardiomyocytes and Non-Myocyte Cells in Cardiac Fibrosis.
    Chu L; Xie D; Xu D
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats.
    Muhammed I; Sankar S; Govindaraj S
    J Cardiovasc Pharmacol; 2018 Feb; 71(2):65-75. PubMed ID: 29419571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction.
    Ramalingam A; Budin SB; Mohd Fauzi N; Ritchie RH; Zainalabidin S
    Sci Rep; 2021 Jul; 11(1):13845. PubMed ID: 34226619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
    Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
    Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy.
    Ghosh AK; Rai R; Flevaris P; Vaughan DE
    J Cell Physiol; 2017 Aug; 232(8):1941-1956. PubMed ID: 27883184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.
    Xu Q; Dalic A; Fang L; Kiriazis H; Ritchie RH; Sim K; Gao XM; Drummond G; Sarwar M; Zhang YY; Dart AM; Du XJ
    Br J Pharmacol; 2011 Mar; 162(5):1012-28. PubMed ID: 20955367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
    Mukhopadhyay P; Rajesh M; Bátkai S; Patel V; Kashiwaya Y; Liaudet L; Evgenov OV; Mackie K; Haskó G; Pacher P
    Cardiovasc Res; 2010 Mar; 85(4):773-84. PubMed ID: 19942623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
    Wang Y; Liao J; Luo Y; Li M; Su X; Yu B; Teng J; Wang H; Lv X
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative stress and molecular changes in liver fibrosis: a review.
    Sánchez-Valle V; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
    Curr Med Chem; 2012; 19(28):4850-60. PubMed ID: 22709007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis.
    Liu ZY; Lin LC; Liu ZY; Yang JJ; Tao H
    Mol Ther; 2024 Apr; 32(4):878-889. PubMed ID: 38311850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile of oxidative stress and antioxidant defense in lung tissue of patients exposed to sulfur mustard.
    Tahmasbpour E; Ghanei M; Qazvini A; Vahedi E; Panahi Y
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():12-21. PubMed ID: 27085470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species and fibrosis: further evidence of a significant liaison.
    Richter K; Kietzmann T
    Cell Tissue Res; 2016 Sep; 365(3):591-605. PubMed ID: 27345301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent Hypoxia Prevents Myocardial Mitochondrial Ca
    Chang JC; Lien CF; Lee WS; Chang HR; Hsu YC; Luo YP; Jeng JR; Hsieh JC; Yang KT
    Cells; 2019 Jun; 8(6):. PubMed ID: 31181855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.
    Wu S; Lan J; Li L; Wang X; Tong M; Fu L; Zhang Y; Xu J; Chen X; Chen H; Li R; Wu Y; Xin J; Yan X; Li H; Xue K; Li X; Zhuo C; Jiang W
    Cell Biol Toxicol; 2023 Feb; 39(1):237-258. PubMed ID: 34713381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure.
    Dai DF; Johnson SC; Villarin JJ; Chin MT; Nieves-Cintrón M; Chen T; Marcinek DJ; Dorn GW; Kang YJ; Prolla TA; Santana LF; Rabinovitch PS
    Circ Res; 2011 Apr; 108(7):837-46. PubMed ID: 21311045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.